On December 9, Gelonghui reported that csc's research report pointed out that ningbo sanxing medical electric (601567.SH) is expected to see a year-on-year growth of 21.91% in net income attributable to the parent company in the first three quarters of 2024, with performance on the rise and coordination of domestic and overseas business increments. In the first three quarters, the gross margin increased by 2.59 percentage points to 36.21%, enhancing profitability. In terms of overseas business, the company has made deep investments in overseas electricity business, with continuous breakthroughs in power distribution overseas; against the backdrop of global smart grid development, the market potential for overseas power distribution and supply is extensive, making it a suitable time for smart meter companies to expand internationally, and opening up new increments in power distribution. Regarding domestic business, the scale of domestic meter bidding in 2024 is expected to be high, reflecting a strong industry sentiment, and the company continues to deeply explore the needs of large customers in the power distribution business. Thanks to the high sentiment in the power equipment sector, the company will fully benefit from the resonance of business increments both domestically and internationally. Looking ahead to the year, the company is expected to specialize in severe rehabilitation, relying on its rich experience in hospital chain management and internal/external talent cultivation system to continuously expand its rehabilitation hospital footprint, and with new hospital revenues climbing and profit margins increasing, the medical sector business is expected to achieve steady growth.